HIF-1α overexpression is associated with tumor aggression for several types including glioblastoma, oligodendroglioma, melanoma, breast, cervical, colon, ovarian, endometrial, lung, prostate, bladder, pancreatic, and oropharyngeal cancer. This evidence concerns the gene HIF1A and oligodendroglioma.